INTRODUCTION {#S0001}
============

Chronic obstructive pulmonary disease (COPD) is the forth major killer disease in the United States ([@CIT0001]), and most of the developed countries ([@CIT0002]). This condition is a leading cause of mortality and morbidity all over the world ([@CIT0001], [@CIT0003], [@CIT0004]). It also contributes to a great economic burden imposed on the communities ([@CIT0001], [@CIT0004]).

Research work regarding various aspects of COPD is greatly encouraged by academic institutions, both for its high prevalence in the world ([@CIT0005]) and because it is potentially preventable ([@CIT0006]) by smoking cessation, and air pollution control.

Cigarette smoking has been identified as the main cause of this disease and many successful attempts have been carried out to inform the population about the risks associated with this behavior. These warnings have resulted in significant changes in the pattern of cigarette smoking in most developed populations, with resultant changes in disease frequency in many communities ([@CIT0007]). These changes include decreased number of smoker men and a paradoxical rise in number of smoker women during the past few decades.

Smoking pattern in Iran is far more different from other parts of the world. In fact, in our community smoker women comprise less than five percent of the population ([@CIT0008]). However, the reported frequency of COPD among Iranian women is not lower than other parts of the world. Therefore, we should look for causes other than smoking for this condition ([@CIT0009], [@CIT0010]). Unfortunately, limitation of research grants confines in-depth works to clarify the problem.

A few epidemiologic studies have been published regarding the prevalence of COPD in Isfahan since 10 years ago ([@CIT0010], [@CIT0011]).

Stressing the seriousness of this condition by reevaluation of previous findings can draw the attention of organizations in charge to promote more efforts in this field.

This study aimed to evaluate the prevalence of chronic bronchitis and/or COPD in Isfahan and assess the changes in the previous decade.

MATERIALS AND METHODS {#S0002}
=====================

The ethical committee of the Isfahan University of Medical Sciences approved this research project.

As a part of Isfahan respiratory epidemiologic survey, we planned to evaluate the prevalence of chronic bronchitis and/or COPD as defined by the global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ([@CIT0012]).

The questionnaire contained questions regarding demographic and occupational details, respiratory symptoms and smoking. The questions were based on the " European Compendium of Respiratory Standard" ([@CIT0013]).

Persian translation of the questionnaire for adults was used for discrimination of suspected COPD cases. The translated version of the questionnaire was back-translated to English by a different individual not involved in the study, to ensure that the spirit of the questionnaire is intact.

For the purpose of randomization, the map of Isfahan was divided into 100 geographic areas, after which one lane from each area was selected by drawing lots. Trained interviewers went to the selected lanes, knocked all the doors of the residential places and asked the residents to answer the questions. Those people who agreed to take part, and signed a written consent were enrolled in the study. Then the interviewer filled out the questionnaire at the presence of subjects.

If some residents were not accessible in the first session, the interviewer had to stop by several times to make the interview or to ensure that the place is not currently in use. A few places used for jobs were excluded from the study.

The completed questionnaires were reviewed by one pulmonologist, and subjects who admitted to have chronic productive cough for at least three months a year in two successive years were asked to perform pulmonary function tests (PFT) and impulse oscillometry to determine if they also have developed obstructive phase of the illness.

The measurement of respiratory impedance by IOS was done with a commercially available oscillatory system (MS-IOS; Masterlab-IOS, Erich Jaeger, Germany), all spirometric measurements were conducted by one technician, the details of which have been described elsewhere ([@CIT0014]), and fulfilled standard recommendations ([@CIT0015]).

Subjects with an obstructive pattern of PFT were retested for 10 minutes after administration of 2 puffs of salbutamol by metered dose inhaler (MDI) to evaluate the reversibility of the obstruction. Meanwhile a sex and age matched group of asymptomatics were also asked to perform PFT and impulse oscillometry in the same described manner to further reassure the reliability of the responses to questionnaires.

A cut-off point of occupational exposure to dusts/gases/fumes for 1 yr classified the subjects into two groups (yes or no) ([@CIT0016]).

The obtained data were collected in a database to be analyzed by using SPSS version 18 software.

We used data from people aged 40 or more to be comparable to more recent international reports ([@CIT0003]).

Frequency tables were used to extract demographic characteristics of the population.

Cross-table test was used to determine the association between clinical and spirometric findings between the two groups with and without COPD.

Multi-nominal regression analysis was used to evaluate the correlation between chronic bronchitis and possible risk factors.

Nonsmoker individuals living with smoker relatives were considered as passive smokers.

RESULTS {#S0003}
=======

In the initial phase, 1,308 subjects out of 2,200 eligible people (59.4%) agreed to take part in the study. The enrolled population consisted of 672 women and 636 men, with an age range of 40 to 94 years.

Unfortunately, response to the second phase was not brilliant. Overall, 279 individuals including 62 symptomatic and 217 asymptomatic cases took part in the study.

Demographic characteristics of the population including BMI, active and/or passive smoking habits and occupational risk categories are summarized in [Table 1](#T0001){ref-type="table"}.

###### 

Distribution of demographic and anthropometric characteristics, smoking pattern and level of education

  Specificities                    Males         Females
  -------------------------------- ------------- -------------
  **Age (Mean±SD) years**          56.35±9.50    59.37±10.43
  ** Age categories**                            
  **  **40-49 years                119(18.7%)    192(28.4%)
  **  **50-59 years                236(37.2%)    253(37.6%)
  **  **60 & higher                280(44.1%)    228(33.9%)
  **BMI**                          25.68± 3.92   27.46±4.92
  Normal weight (BMI 25 or less)   300(47.2%)    200(29.8%)
  Over weight ( BMI \>25 \< 30)    252(39.6%)    298(44.3%)
  Obese (BMI \>30)                 84(13.2%)     174(25.9%)
  **Ever smoker**                  141(22.2%)    3(0.4%)
  **Education**                                  
  Junior high-school or lower      344(54.1%)    484(72%)
  High school                      219(34.4%)    159(23.7%)
  University                       73(11.5%)     29(4.3%)
  **Total number (1308)**          636 (48.6%)   672 (51.4%)

[Table 2](#T0002){ref-type="table"} presents the frequency of self reported respiratory symptoms including chronic bronchitis as defined above.

###### 

Self --reported symptoms

  Variable                                            Male         Female     P value
  --------------------------------------------------- ------------ ---------- ---------
  Chronic morning cough                               109(17.1%)   52(7.7%)   0.000
  Chronic cough during the day                        87(13.7%)    45(6.7%)   0.000
  Chronic bronchitis by classic clinical definition   81(12.7%)    26(3.9%)   0.000

[Table 3](#T0003){ref-type="table"} shows the comparisons of the spirometric findings in the symptomatic versus the asymptomatic groups.

###### 

Characteristics of those undergoing pulmonary function test and impulse oscillometry

                                          With clinical COPD   Without clinical COPD   P value
  --------------------------------------- -------------------- ----------------------- ---------
  Total number                            62                   217                     
  Mean FVC(liters)                        3.08±1.07            3.61±1.06               0.00
  Mean FVC post-bronchodilator(liters)    3.09±1.03            3.68±1.06               0.00
  Mean FEV1(liters)                       2.36±0.88            2.99±0.93               0.00
  MeanFEV1 post-bronchodilator(litters)   2.42±0.84            3.11±0.95               0.00
  Mean FEV1/FVC                           78.55±10.17          83.54±9.61              0.00
  Mean FEV1/FVC post-bronchodilator       76.49±14.01          85.30±10.25             0.00
  R5                                      0.51±0.36            0.47±0.33               0.35
  R5 post-bronchodilator                  0.48±0.31            0.42±0.25               0.18
  R25                                     0.39±0.32            0.34±0.19               0.23
  R25 post-bronchodilator                 0.33±0.18            0.32±0.25               0.93
  Zbi                                     0.54±0.36            0.50±0.36               0.46
  Zbi post-bronchodilator                 0.53±0.34            0.47±0.38               0.39

[Table 4](#T0004){ref-type="table"} shows the relationships between chronic bronchitis and/or COPD and various risk factors.

###### 

Predictors of COPD (FEV1 \< 80% predicted and FEV1/FVC \< 0.7) against potential explanatory variables.

  Variables                   Number(%)    Odds ratio (95% CI)   P value
  --------------------------- ------------ --------------------- ---------
  **Age- categories**                                            
   40-49 years                311(23.7)    0.29(0.11-0.70)       \<0.001
   50-59 years                489(37.4)    0.23(0.10-0.51)       
   60 years and over          508(38.9)    1                     
  **BMI**                                                        
  Normal                      500(38.3)    0.60(0.27-1.33)       0.45
  Overweight                  549(42)      0.76(0.35-1.65)       
  Obese                       258(19.7)    1                     
  **Smoking**                                                    
  Smoker                      144(11)      1.17(0.29-4.72)       \<0.001
  Nonsmoker                   1136(88.9)   0.24(0.06-0.89)       
  Exsmoker                    27(2.1)      1                     
  Passive smoker              171(13)      1.15(0.43-3.08)       0.77
  No smoker at home           1136(86.9)   1                     
  **Education**                                                  
  Junior high-school /lower   827(63.3)    0.55(0.19-1.54)       0.19
  High school                 378(28.9)    0.33(0.10-1.09)       
  University                  102(7.8)     1                     

Multivariate logistic regression analysis: P \< 0.05 was considered as a cutoff point for significance

There was a significant reverse correlation between smoking and age in our understudy subjects.

DISCUSSION {#S0004}
==========

Since there are only a few available epidemiological studies on the prevalence of COPD in Iran ([@CIT0009]--[@CIT0011]), a true comparison between various parts of the country is not possible. Furthermore, follow-up studies have never been published.

Cross-sectional epidemiologic studies are valuable tools to evaluate the overall situation of the disorders which is necessary for health care providers to adjust their priority in using evaluation methods when facing symptoms referring to multiple disorders, and also these information are necessary for community health programmers to provide adequate facilities, health care programs, and research opportunities to find the important etiologic factors, and in order to try to control the situation.

Repeated studies in certain intervals can elucidate the efficacy of preventive measures applied during the interval.

To the best of our knowledge, this is the first interval study performed in Iran regarding the prevalence of COPD. According to such comparisons, the prevalence of chronic bronchitis as the first/main sign of COPD increased significantly in Isfahan during 1999-2010. The methodology of the two has been the same, but we had a five year older population in the new series which might have minimal effects on the increased frequency of COPD, however the almost two-fold increment can not be explained by this five year age difference.

An earlier published study in Isfahan in 1999 showed the frequency of chronic bronchitis in Isfahan to be 6.85% and 3.1% in men and women respectively. In the current study, the frequencies raised to 12.7% in men and 3.9% in females. This increase might be more alarming when we notice that the prevalence of smoking among Isfahan male residents not only did not increase during the past 10 years ([@CIT0008]--[@CIT0011]), but also showed a minimal decrement (25.3% current smokers in 1999 versus 22.2% ever smokers in the current study), a fact which implies that anti-smoking warnings provided by health care workers and global mass media have been effective and are approaching the ideal goals. However, other factors including increased air pollution both from traffic sources and industries and poor job conditions are also possible extra contributors to the problem.

Increasing age is a known risk factor for COPD. In fact the older a person gets, the greater the chance of continued exposure to smoke and air pollutants.

Unfortunately, occupation as a risk factor for respiratory illnesses in men in Isfahan has always been a difficult matter of discussion, since most people do not declare their accurate job, for fear of a possible tax increment and furthermore, many people have multiple jobs with different respiratory risks, while they only declare their official job, and ignore the others. Therefore, the risk estimation of job exposures was not elucidative in our study.

We have to increase the awareness about COPD and its related risk factors in our population. Also, the negative trend observed in this survey must be further evaluated in future studies.

This study was granted by Isfahan University of Medical Sciences and Bamdad Institution of Respiratory Research.
